Announcement:

The results of a recent collaboration between Sanofi, GSK, Lilly, Vesalius Therapeutics, Leiden University, Heidelberg University, ElmorePathology and Newcells aimed at enhancing safety assessments has just been published. Find out how rat kidney gene co-expression networks has enabled biomarker identification and human translation for renal safety assessments.

Find out more

Home › Resources › Videos and webinars › The Real Impact of In Vitro Kidney Models: Better Data, Safer Drugs

The Real Impact of In Vitro Kidney Models: Better Data, Safer Drugs

During this webinar you will hear from our 2 panelists Dr David Rodrigues and Dr Elad Katz, moderated by Dr Colin Brown, discussing the real impact of in vitro kidney models in producing higher quality data and ultimately safer drugs.

Date: Wednesday 7th May 2025

Speakers:

Dr David Rodrigues, PhD – Associate VP Head of Drug Metabolism & Nonclinical Pharmacokinetics – Incyte
Dr Elad Katz, PhD – Founder – Navigate Precision Biology
Dr Colin Brown, PhD – Chief Scientific Officer – Newcells Biotech

Published

May 7, 2025

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View Today

Please enter the required details to view the webinar. You are not automatically signing up for receiving marketing emails.

Book a Call